Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.11 - $0.83 $1,036 - $7,820
9,422 Added 265.41%
12,972 $1,000
Q3 2022

Nov 10, 2022

BUY
$1.27 - $3.39 $4,508 - $12,034
3,550 New
3,550 $4,000
Q1 2022

May 12, 2022

SELL
$2.86 - $8.83 $483 - $1,492
-169 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.94 - $8.94 $834 - $1,510
169 New
169 $1,000
Q3 2021

Nov 15, 2021

SELL
$6.05 - $10.81 $26,632 - $47,585
-4,402 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$4.56 - $11.45 $14,218 - $35,701
3,118 Added 242.83%
4,402 $30,000
Q1 2021

May 17, 2021

BUY
$11.65 - $37.0 $14,958 - $47,508
1,284 New
1,284 $16,000

Others Institutions Holding LHDX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Lucira Health, Inc.


  • Ticker LHDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,106,500
  • Market Cap $1.2M
  • Description
  • Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...
More about LHDX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.